Company: CERO
Filing Date: 2025-01-21
Form Type: S-1/A
Source: 0001213900-25-004742
Chunk: 288

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-01-21
Form: S-1/A
Chunk 288
---
 agreement will also be able to bring claims of breach of contract against us. The nature of the representations, warranties and covenants in the placement agency agreement shall include:

| ● | standard issuer representations and warranties on matters                                                                                 
 such as organization, qualification, authorization, no conflict, no governmental filings required, current in SEC filings, no litigation, 
 labor or other compliance issues, environmental, intellectual property and title matters and compliance with various laws such as the     
 Foreign Corrupt Practices Act; and                                                                                                        |

| ● | covenants regarding matters such as no integration with other                                                                              
 offerings, filing of a Current Report on Form 8-K to disclose the consummation of the offering and entry in securities purchase agreements 
 and the placement agency agreement, no shareholder rights plans, no material nonpublic information, use of proceeds, indemnification,      
 reservation and listing of common stock.                                                                                                   |

Delivery of the shares of Common Stock, Pre-Funded Warrants and Offered Common Warrants offered hereby is expected to occur on or about , 2025, subject to satisfaction of certain customary closing conditions. We have agreed to pay the placement agent an aggregate fee equal to 7% of the gross proceeds received in the offering. In addition, we have agreed to reimburse the placement agent for its legal fees and expenses and other out-of-pocket expenses in an amount up to $100,000. We estimate the total expenses of this offering paid or payable by us, exclusive of the placement agent’s cash fee of 7% of the gross proceeds and expenses, will be approximately $ 400,000. After deducting the fees due to the placement agent and our estimated expenses in connection with this offering, we expect the net proceeds from this offering will be approximately $8.3 million. The following table shows the per share and total cash fees we will pay to the placement agent in connection with the sale of the Common Stock, Pre-Funded Warrants, Offered Common Warrants and shares of Common Stock underlying the Pre-Funded Warrants and Offered Common Warrants pursuant to this prospectus.

|                                  |     |   | Per Share          
 and Offered Common 
 Warrant            |     |   | Per Pre-Funded      
 Warrant and Offered 
 Common Warrant      |     |   | Total |
|:---------------------------------|:----|:--|:-------------------|:----|:--|:--------------------|:----|:--|:------|
| Public offering price            |     | $ |